DONATE NOW

Radiation and Laser Treatment

For most people with OM, the first goal is to destroy the tumor inside the eye while keeping the eye and as much vision as possible. Radiation is the most common way to do this.

The landmark Collaborative Ocular Melanoma Study (COMS) found that, for medium-sized tumors, patients treated with radiation lived just as long as patients whose eye was removed. That finding made eye-sparing radiation the standard of care for most tumors.

Radiation does not make the tumor disappear right away. It damages the cancer cells’ DNA so they can no longer divide, and the tumor shrinks slowly over months to years. Often a flat, inactive scar remains. Regular eye exams and scans after treatment confirm the tumor is under control.

It is also important to know what radiation of the eye can and cannot do. It controls the tumor in the eye, but it does not change whether cancer cells had already traveled elsewhere before treatment. That is why ongoing body scans are recommended after treatment.

Plaque brachytherapy ("plaque therapy")

Brachytherapy (BRAK-ee-THER-uh-pee) means placing a radiation source right next to the tumor, rather than aiming a beam from outside the body. It is the most widely used treatment for uveal melanoma.

  • How it works: A small, coin-sized metal disc called a plaque is lined with tiny radioactive seeds, each about the size of a grain of rice. The plaque is custom-designed for your tumor’s size and location. In a short operation, the eye surgeon stitches it to the outside wall of the eye, directly over the tumor. The radiation passes through the wall of the eye into the tumor, with less exposure to healthy tissue nearby.
  • Types of seeds: Iodine-125 is the most common in the United States. Palladium-103 and ruthenium-106 are also used, and ruthenium-106 is more common in Europe. Each delivers radiation slightly differently. Your specialist can explain which plaque gives the best protection to the parts of the eye most important for vision, such as the optic nerve and the macula.
  • What to expect: The plaque usually stays in place for about 5 to 7 days and is then removed in a second short procedure. Depending on the center, you may stay in the hospital or go home with a lead shield over the eye. The radiation itself is painless, though the eye may feel scratchy or sore from the stitches.
  • How well it works: Plaque therapy controls the tumor in the eye in roughly 9 out of 10 patients or more. Modern image-guided techniques report even higher rates.
  • Side effects: Radiation also affects the healthy parts of the eye. The most common long-term effects are cataract and damage to the retina or optic nerve (radiation retinopathy or optic neuropathy). These can develop months to years after treatment. In the original COMS study, about half of patients had a significant loss of vision within three years. Newer planning methods, lower doses and treatments such as eye injections for radiation retinopathy are helping more patients keep useful vision.

Dr. Paul Finger has a helpful overview of plaque therapy on his New York Eye Cancer Center website.

External beam radiation (teletherapy)

External beam radiation aims radiation at the tumor from a machine outside the body, so nothing is attached to the eye during treatment. It may be recommended when a tumor is too large for a plaque, sits close to the optic nerve, or is in a spot a plaque can’t reach well.

Proton beam therapy. Protons are tiny particles that can be aimed very precisely and stop at a set depth, releasing most of their energy inside the tumor. This lets doctors deliver a high dose to the tumor while limiting radiation to tissue behind it, such as the optic nerve.

  • Before treatment: A surgeon stitches several tiny metal markers (tantalum clips) to the outside of the eye so the beam can be lined up exactly.
  • Treatment: It is usually given in 4 to 5 short daily sessions over about a week. You keep your head still in a custom mask and focus your gaze on a small light.
  • How well it works: Large studies show tumor control in about 95% of patients at five years. Many experts consider protons and plaques roughly equal in tumor control and survival, and no head-to-head randomized trial has compared them.
  • Side effects: Because the beam passes through the front of the eye to reach the tumor, protons are more likely than plaques to cause eyelash loss, dry eye, eyelid irritation and cataract. Radiation retinopathy can also occur.
  • Availability: Proton therapy for the eye is offered at a limited number of specialized centers.

Transpupillary thermotherapy (TTT)

TTT is a laser treatment that heats the tumor rather than radiating it. A special infrared laser is aimed through the pupil to slowly warm the tumor enough to kill cancer cells, while limiting damage to the retina on top of it. It is done in the eye clinic.
TTT was once used on its own for small tumors. It has largely fallen out of use as a stand-alone treatment because the tumor returned too often, in roughly 1 in 5 patients in some reviews. Today it is mainly used together with plaque therapy (sometimes called “sandwich therapy”) or to treat a small regrowth after radiation.

Choosing a treatment

The best option depends on the tumor’s size, its exact location in the eye, your vision in both eyes, your overall health and the expertise at your treatment center. Because OM is rare, it is worth being treated, or at least getting a second opinion, at a center that treats many eye melanomas. Ask your specialist why they recommend one approach over another, and what it means for your vision over time.

For new approaches under study, including a light-activated drug designed to treat small tumors while protecting vision, see Frontier Treatments.

This information is for education only. Please talk with your eye cancer specialist about which treatment is right for you.
Introduction
Primary Tumor Treatments
    > Radiation / Laser Treatment
    Enucleation / Resection
    Adjuvant Therapy
Metastatic Disease Treatments
    Targeted Radiation
    Transarterial Chemotherapy
    Other Liver Treatments
    Systemic Treatments
    Clinical Trials
    Frontier Treatments
Diet & Lifestyle
Living with OM